المؤلفون: Paul M. Kuhn, Gabriella C. Russo, Ashleigh J. Crawford, Aditya Venkatraman, Nanlan Yang, Bartholomew A. Starich, Zachary Schneiderman, Pei-Hsun Wu, Thi Vo, Denis Wirtz, Efrosini Kokkoli

المصدر: Pharmaceutics, Vol 16, Iss 8, p 981 (2024)

مصطلحات موضوعية: MEK inhibitor, doxorubicin, E-cadherin positive breast cancer, hydrogel, PR_b-targeted liposomes, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1999-4923/16/8/981; https://doaj.org/toc/1999-4923

URL الوصول: https://doaj.org/article/82dc066e2d0342a38840b85efed4ae52